Improvements in Skin and Nail Psoriasis are Positively Correlated across Systemic Psoriasis Therapies
Journal Title: Journal of Dermatology Research - Year 2023, Vol 4, Issue 2
Abstract
Objective: For clinical scenarios where patients have moderate to severe psoriasis and nail psoriasis, knowing whether skin response is correlated with nail response would provide insight into the relationship between psoriatic skin and nail unit inflammation. The primary objective of this study was to determine if improvement in skin and nail psoriasis across a range of systemic therapies are correlated. Methods: Relevant publications pertaining to systemic therapies approved in the US for psoriasis were identified via PubMed search. Only studies with placebo controls were included. The paired point estimates of the PASI 75 response treatment effect [i.e., the placebo-adjusted PASI 75 response rate] (independent variable) and mean percentage NAPSI improvement for target fingernail treatment effect [also placebo-adjusted] (dependent variable) were calculated for each therapy. Simple linear regression analysis weighted by the standard errors for the independent and dependent variables was performed. Results: Ten paired treatment effects for 4 systemic therapies (apremilast, adalimumab, etanercept, and guselkumab) were obtained. Guselkumab and adalimumab were associated with the greatest nail improvement, and guselkumab was associated with the greatest skin response rate. PASI 75 response rate and mean percentage improvement target fingernail NAPSI were positively correlated (p=0.03), with an R2 value of 0.48. Conclusions: There is significant positive correlation across different therapies between the magnitude of improvement in psoriatic skin and nail disease among patients with moderate-severe psoriasis and clinically significant nail disease.
Authors and Affiliations
Thomas SD Okun, Martin M Okun
Keywords
Related Articles
- EP ID EP717027
- DOI https://doi.org/10.46889/JDR.2023.4203
- Views 55
- Downloads 0
Dermatoscopic, Ultrasound and Histopathological Findings of Bullous Pilomatricoma: A Case Report
Pilomatricoma is the second most common benign tumor in the pediatric population after the epidermal cyst. It presents clinically as a firm, painless, solitary, well-defined nodule. Bullous presentation is rare, so we pr...
Rheumatoid Vasculitis: Heterogeneous Clinical Presentation
Vasculitis is defined as a vascular inflammation which may be localized or systemic and mostly idiopathic. Usually it affects several organs of the body such as skin, kidneys and lungs. Vasculitis is one of the biggest...
Successful Treatment of Pityrosporum Folliculitis with Isotretinoin
Pityrosporum Folliculitis (PF) is a condition characterized by pruritic 1-2 mm monomorphic follicular papules and pustules on the upper back, chest and shoulders. PF is caused by overgrowth of Malassezia furfur, a commen...
Smartphone-Assisted Artificial Intelligence in Dermatology- A Novel Approach to Help General Practitioners in Underserved Areas
Artificial intelligence is a branch of computer science that deals with the development of computer programs that aims to reproduce the human intelligence process [1]. Artificial intelligence has a crucial role to play i...
Impact of the Affordable Care Act on Insurance Status of Patients Newly Diagnosed With Kaposi Sarcoma
Background: The Affordable Care Act (ACA) role in changing the insurance composition of patients diagnosed with many dermatological conditions, such as Kaposi Sarcoma (KS), has not been assessed. Methods: The Surveill...